首页> 外文OA文献 >Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients
【2h】

Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients

机译:肝门部胆管癌手术治疗后围手术期和长期预后的改善:440例意大利多中心分析的结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE: To evaluate improvements in operative and long-term results following surgery for hilar cholangiocarcinoma.\ud\udDESIGN: Retrospective multicenter study including 17 Italian hepatobiliary surgery units.\ud\udPATIENTS: A total of 440 patients who underwent resection for hilar cholangiocarcinoma from January 1, 1992, through December 31, 2007.\ud\udMAIN OUTCOME MEASURES: Postoperative mortality, morbidity, overall survival, and disease-free survival.\ud\udRESULTS: Postoperative mortality and morbidity after liver resection were 10.1% and 47.6%, respectively. At multivariate logistic regression, extent of resection (right or right extended hepatectomy) and intraoperative blood transfusion were independent predictors of postoperative mortality (P = .03 and P = .006, respectively); in patients with jaundice, mortality was also higher without preoperative biliary drainage than with biliary drainage (14.3% vs 10.7%). During the study period, there was an increasingly aggressive approach, with more frequent caudate lobectomies, vascular resections, and resections for advanced tumors (T stage of 3 or greater and tumors with poor differentiation). Despite the aggressive approach, the blood transfusion rate decreased from 81.0% to 53.2%, and mortality slightly decreased from 13.6% to 10.8%. Median overall survival significantly increased from 16 to 30 months (P = .05). At multivariate analysis, R1 resection, lymph node metastases, and T stage of 3 or greater independently predicted overall and disease-free survival.\ud\udCONCLUSIONS: Surgery for hilar cholangiocarcinoma has improved with decreased operative risk despite a more aggressive surgical policy. Long-term survival after liver resection has also increased, despite the inclusion of cases with more advanced hilar cholangiocarcinoma. Preoperative biliary drainage was a safe strategy before right or right extended hepatectomy in patients with jaundice. Pathologic factors independently predicted overall and disease-free survival at multivariate analysis.
机译:目的:评估肝门胆管癌手术后的长期和手术效果。\ ud \ ud设计:回顾性多中心研究,包括意大利的17个肝胆外科手术单元。\ ud \ ud患者:总共440例接受了肝门胆管癌切除术的患者1992年1月1日至2007年12月31日。主要观察指标:术后死亡率,发病率,总生存期和无病生存期。\ ud \ ud结果:肝切除术后的术后死亡率和发病率分别为10.1%和47.6%。 , 分别。在多因素logistic回归分析中,切除范围(右或右延长肝切除术)和术中输血是术后死亡率的独立预测因子(分别为P = .03和P = .006);黄疸患者中,术前不进行胆道引流的死亡率也高于胆道引流(14.3%vs 10.7%)。在研究期间,采用了越来越积极的方法,尾状肺叶切除术,血管切除术和晚期肿瘤(T分期为3或更大,分化差的肿瘤)的切除术更加频繁。尽管采取了积极的方法,输血率从81.0%下降到53.2%,死亡率从13.6%下降到10.8%。中位总生存期从16个月增加到30个月(P = 0.05)。在多变量分析中,R1切除,淋巴结转移和3或3个以上的T期可独立预测总体生存率和无病生存期。结论:尽管采取了更为积极的手术策略,但肝门胆管癌的手术治疗有所改善,但手术风险有所降低。尽管纳入了晚期肝门胆管癌病例,但肝脏切除术后的长期存活率也有所提高。黄疸患者在进行右或右延长肝切除术之前,术前胆道引流是一种安全的策略。在多变量分析中,病理因素独立预测总体生存率和无病生存率。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号